Skip to main content

heart failure Archives

Global effort tracks causes, treatment of acute heart failure

Jan. 16, 2020—Patients in North America wait a median of three hours to receive intravenous therapy for acute heart failure, while no other region in the world waited for more than 1.2 hours, according to a global study whose lead author and co-primary investigator is Sean Collins, MD, MSc, professor of Emergency Medicine.

Read more


Cardiac dysfunction in DMD

Mar. 28, 2019—The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

Read more


Enzyme protects against obesity-related heart disease

Jun. 7, 2018—Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.

Read more


Heart failure risk predicted by communities, not wealth

Jan. 9, 2018—When buying and selling real estate, how often have you heard the realtor’s mantra — location, location, location? This is also the central theme of a recently released journal report on factors that can predict heart failure risk.

Read more


My Southern Health: Heart failure – it’s not what you think

May. 24, 2017—Heart failure is more prevalent in the South. Here’s what you need to know.

Read more


HIV-infected people have higher risk of heart failure

Apr. 27, 2017—The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology.

Read more


Heart failure “dashboard”

Jan. 5, 2017—A new computer algorithm developed at Vanderbilt could save billions of dollars in health care costs by identifying patients at risk for readmission after being hospitalized for heart failure.

Read more


Pregnancy-related heart disorder clues

Jun. 3, 2016—Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.

Read more


Heart Institute celebrates LVAD program milestone

Apr. 14, 2016—On April 7, a 48-year-old man from Bethpage, Tennessee, became the 300th person to receive a left ventricular assist device (LVAD) at Vanderbilt Heart and Vascular Institute (VHVI).

Read more


Heart repair factor

Sep. 17, 2015—A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.

Read more


New device monitors pulmonary artery pressures

Aug. 20, 2015—For patients with heart failure, changes in pulmonary artery (PA) pressures are an early indication that their condition is worsening, even before they notice symptoms such as shortness of breath or weight gain.

Read more


Study seeks to bolster outcomes for acute heart failure patients

May. 21, 2015—With support from a three-year, $2 million research grant from Patient-Centered Outcomes Research Institute (PCORI), Vanderbilt University Medical Center and the American Heart Association are teaming up to study heart failure care in the Emergency Department.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more